arrow
E

Elizabeth M. Jaffee

Johns Hopkins University
H指数:112
被引数:5.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial

奥拉帕尼与尼沃鲁单抗联合治疗微卫星稳定型结直肠癌:一项1/2期临床试验

2026-07-230
OA
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial

携带KRAS突变肽疫苗及双重检查点封锁的转移性结直肠癌:一项I期临床试验

2026-06-230
OAAI
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

Publisher Correction: 突变KRAS疫苗联合双重免疫检查点阻断在切除的胰腺癌中的I期临床试验

2026-04-150
OAAI
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study

联合使用癌症疫苗、pembrolizumab 和立体定向体部放射治疗局部晚期胰腺癌患者的疗效:一项单臂、II 期研究

2026-03-180
OAAI
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

携带双检查点阻断的突变KRAS疫苗在切除的胰腺癌中的应用:一项I期临床试验

2026-02-100
OAAI
An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations

甲状腺癌进展的整合单细胞和空间转录组学图谱鉴定出具有预后价值的成纤维细胞亚群

2026-01-090
PRE
Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer

合成长肽和DNA个性化癌症疫苗在胰腺癌中诱导强烈的neoantigen特异性T细胞反应

2026-01-010
OA
Comparative assessment of physiochemical metrics for the clustering of adaptive immune receptor repertoires

适应性免疫受体库聚类中物理化学指标的对比评估

2025-11-260
OAAI
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

一种纤维层状肝细胞癌的治疗性多肽疫苗:一项1期临床试验

2025-11-240
OAAI
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC

DNAJ-PKAc诱导纤维层状肝细胞癌的代谢重编程及谷氨酰胺通量增强

2025-11-060
PRE
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy

与接受免疫检查点抑制剂治疗的癌症患者疲劳相关的免疫激活特征

2025-10-010
OAAI
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages

一项关于CXCR4拮抗和PD1抑制在转移性胰腺腺癌中的Ⅱ期试验显示,招募了T细胞但也招募了免疫抑制性巨噬细胞。

2025-08-150
OAAI
Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories

人类可解释的语法对多细胞系统生物学模型进行编码,以实现虚拟细胞实验室的民主化。

Cell
IF42.5
2025-07-260
OAAI
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

实体瘤患者接受免疫检查点抑制剂治疗后,年龄相关的循环免疫反应差异

2025-04-210
OA
EphA2-targeted alpha-particle theranostics for PDAC treatment

EphA2靶向α粒子诊疗一体化在PDAC治疗中的应用

2025-03-180
OA
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma
2025-03-011
PRE